Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600 million round was led by Thrive Capital, with ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The company will build off of breakthroughs in protein prediction from DeepMind and inches Big Tech one step further into the healthcare industry. Reading time 2 minutes Alphabet has spun off a new ...

Alphabet has created a new subsidiary called Isomorphic Labs that will focus on using AI processes to develop new drugs. An offshoot from Deepmind, another AI subsidiary of Alphabet, the idea for ...

Last year, researchers at DeepMind showed they were able to help solve a riddle that has stumped scientists for decades: How do proteins repeatedly fold themselves into the proper shapes? (Getty ...

Google parent Alphabet has drawn on its DeepMind artificial intelligence division to form a drug discovery unit that it calls Isomorphic Labs. The UK-registered company will be able to tap into ...

Roland is a technology enthusiast who loves to tinker and geek out about the latest smartphones, tablets, smartwatches, and other wearables and gadgets. He aims to provide honest reviews and thoughts ...